Monograph Details
|
|
Pain & Pyrexia
> Topical analgesics/anesthetics
|
|
LIDODERM |
| Manufacturer |
|
Endo Pharmaceuticals |
| Legal Classification |
|
Rx
|
| Pharmacological Class |
|
Topical anesthetic. |
| Generic Name |
|
Lidocaine 5%; adhesive patch. |
| Indications |
|
Postherpetic neuralgia. |
| Children |
|
Not recommended. |
| Adults |
|
Apply to intact skin, covering most painful area. To adjust dose, cut patches before removing release liner. Remove if irritation or burning occurs; do not reapply until irritation subsides. May apply up to 3 patches at once for up to 12 hours of a 24-hour period. Hepatic impairment or debilitated: use smaller treatment areas. |
| Precautions |
|
Do not apply to broken or inflamed skin. Avoid eyes, mucous membranes, longer duration of application, and application of more than 3 patches. Do not ingest; may be toxic to children and pets. Hepatic disease. Small patients. Pregnancy (Cat.B). Labor & delivery. Nursing mothers. |
| Interactions |
|
Toxicity may be potentiated by Class I antiarrhythmics (e.g., tocainide, mexiletine). Additive effects with other local anesthetics. |
| Adverse Reactions |
|
Local effects (e.g., erythema, edema), allergic reactions (e.g., urticaria, angioedema, bronchospasm). |
| How Supplied |
|
Patches (10cm x 14cm)—30 |
|
|
|
|
